Mark E. Rupp

20.0k citations

186 papers · 12.3k indexed · 5 hit papers · h-index 51

Emergency Medical Services top 0.01%
- Central Venous Catheters and Hemodialysis 32
Applied Microbiology and Biotechnology top 0.1%
- Antibiotic Use and Resistance 16
Infectious Diseases top 0.1%
- Antimicrobial Resistance in Staphylococcus 55
- Infection Control in Healthcare 23
Clinical Biochemistry top 0.1%
- Bacterial Identification and Susceptibility Testing 35
Critical Care and Intensive Care Medicine top 0.2%
Epidemiology
- Infective Endocarditis Diagnosis and Management 21
Molecular Biology
- Bacterial biofilms and quorum sensing 20
Public Health, Environmental and Occupational Health
- Streptococcal Infections and Treatments 19

Co-authors: Paul D. Fey Leonard A. Mermel Naomi P. O’Grady Peter C. Iwen Lillian A. Burns E. Patchen Dellinger Pamela A. Lipsett Jeffrey Garland
Cited by: Emergency Medical Services Applied Microbiology and Biotechnology Infectious Diseases
Journals: Infection Control and Hospital Epidemiology (52 papers)Open Forum Infectious Diseases (16 papers)Clinical Infectious Diseases (15 papers)
Partner nations: United States Germany Switzerland

In The Last Decade

Mark E. Rupp

175 papers receiving 11.7k citations

Hit Papers

5 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2022 Infection Control and Hospital Epidemiology
2014 Infection Control and Hospital Epidemiology
2011 Clinical Infectious Diseases
2011 Clinical Infectious Diseases
2011 American Journal of Infection Control

Peers

Countries citing papers authored by Mark E. Rupp

Since Specialization

Citations

This map shows the geographic impact of Mark E. Rupp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Rupp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Rupp more than expected).

Fields of papers citing papers by Mark E. Rupp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Rupp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Rupp. The network helps show where Mark E. Rupp may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark E. Rupp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark E. Rupp Line = papers co-authored together Mark E. Rupp links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Utilizing whole genome sequencing to characterize central line-associated bloodstream infections due to Staphylococcus epidermidis Infection Control and Hospital Epidemiology ·Suar Oh,Michael R. Wiley,John E. Wiley,Kelly Cawcutt,Georges Thibierge,Kathie L. Rogers,Emily McCutchen,Peter C. Iwen,Paul D. Fey,Mark E. Rupp	2025	0
2	Intravascular Catheter-Related Bloodstream Infections Infectious Disease Clinics of North America ·Srinivasa Kandala,Mark E. Rupp,Kelly Cawcutt	2024	1
3	Effect of the COVID-19 pandemic on occupational risk for bloodborne pathogen exposure among health care providers American Journal of Infection Control ·Jacques Thomassin,Mark E. Rupp,Dư Anh Thơ,Elizabeth Lyden,Richard Starlin	2024	0
4	Evaluation of cycle threshold values at deisolation Infection Control and Hospital Epidemiology ·D. A. Ramsay,Hannah M. Creager,Kelly Cawcutt,Ekaterina V. Raizikh,Elizabeth Lyden,Trevor Van Schooneveld,Mark E. Rupp,Angela Hewlett	2021	14
5	Improving antibiotic prescribing for acute bronchitis in the ambulatory setting using a multifaceted approach Infection Control and Hospital Epidemiology ·Philip Chung,幸夫須藤,Muhammad Salman Ashraf,Scott Bergman,A. V. Brantov,Mark E. Rupp,Michelle Schwedhelm,Maureen Tierney,Francisco R. Ordaz-Zurita,Trevor Van Schooneveld,Jasmine R Marcelin	2021	4
6	Improving hospital-based point-of-care ultrasound cleaning practices using targeted interventions: a pre–post study The Ultrasound Journal ·Alvaro Lima,Daniel Jarman,Elizabeth Lyden,Mark E. Rupp,Christopher J. Smith	2021	2
7	Exebacase for patients with Staphylococcus aureus bloodstream infection and endocarditis Journal of Clinical Investigation ·Vance G. Fowler,Anita Das,R. Garipelly,Raymond Schuch,Roger J. Pomerantz,Luis Jáuregui-Peredo,Adam Bressler,David C. Evans,Gregory J. Moran,Mark E. Rupp,Robert A. Wise,G. Ralph Corey,Marcus Zervos,Pamela S. Douglas,Cara Cassino	2020	95
8	Guideline-Concordant Versus Discordant Antimicrobial Therapy in Patients With Community-Onset Complicated Intra-abdominal Infections Infection Control and Hospital Epidemiology ·Josephine Bonos,Trevor Van Schooneveld,Bessan Hamed Dababseh,Keith M. Olsen,Mark E. Rupp,Alan E. Gross	2016	3
9	Infectious Disease Physicians' Perceptions About Ebola Preparedness Early in the US Response: A Qualitative Analysis and Lessons for the Future Health Security ·Scott Santibañez,Philip M. Polgreen,Susan E. Beekmann,Mark E. Rupp,Carlos del Rı́o	2016	5
10	Healthcare Personnel Attire in Non-Operating-Room Settings Infection Control and Hospital Epidemiology ·Gonzalo Bearman,Kristina A. Bryant,Surbhi Leekha,Jeanmarie Mayer,L. Silvia Muñoz-Price,Rekha Murthy,Tara N. Palmore,Mark E. Rupp,Joshua P. White	2014	83
11	Epidemiology and Predictors of Multidrug-Resistant Community-Acquired and Health Care-Associated Pneumonia Antimicrobial Agents and Chemotherapy ·Alan E. Gross,Trevor Van Schooneveld,Keith M. Olsen,Mark E. Rupp,正英大津,Л В Павлей,André C. Kalil	2014	99
12	Is Incidental Recovery of Yeast from Enteric Pathogen Stool Cultures Obtained from Hospitalized Patients Clinically Significant? SHILAP Revista de lepidopterología ·Peter Watkinson,Peter C. Iwen,京子坂口,Mark E. Rupp,Elizabeth D. Hermsen	2011	1
13	Is incidental recovery of yeast from enteric pathogen stool cultures obtained from hospitalized patients clinically significant? Infectious Disease Reports ·Elizabeth D. Hermsen,Peter Watkinson,Peter C. Iwen,Fang Qiu,Mark E. Rupp	2011	1
14	Inappropriate intravascular device use: a prospective study Journal of Hospital Infection ·Manish Tiwari,Elizabeth D. Hermsen,Martin Charlton,J R Anderson,Mark E. Rupp	2011	27
15	Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: A systematic review and meta-analysis* Critical Care Medicine ·André C. Kalil,Kai Yee Toh,Elizabeth D. Hermsen,Felipe Kalil Neto,Junfeng Sun,Mark E. Rupp	2010	83
16	Guidelines for the prevention of the intravascular catheter‐related infections Nutrition in Clinical Practice ·Naomi P. O’Grady,Mary Alexander,Lillian A. Burns,E. Patchen Dellinger,Jeffrey Garland,Stephen O. Heard,Pamela A. Lipsett,Henry Masur,Leonard A. Mermel,Michele L. Pearson,Issam Raad,Adrienne G. Randolph,Mark E. Rupp,Sanjay Saint,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	2003	38
17	Extended Spectrum ??-Lactamase (ESBL)-Producing Enterobacteriaceae Drugs ·Mark E. Rupp,Paul D. Fey	2003	292
18	Environmental Contamination With Vancomycin-Resistant Enterococci in an Outpatient Setting Infection Control and Hospital Epidemiology ·Theresa L. Smith,Peter C. Iwen,Maiko Katadae,Mark E. Rupp	1998	30
19	Invasive Mold Sinusitis: 17 Cases in Immunocompromised Patients and Review of the Literature Clinical Infectious Diseases ·Peter C. Iwen,Mark E. Rupp,Steven H. Hinrichs	1997	102
20	Meningitis Due to Neisseria mucosa: Case Report and Review Clinical Infectious Diseases ·Jennifer L. Stotka,Mark E. Rupp,Frederick A. Meier,Sheldon M. Markowitz	1991	10

About Mark E. Rupp

Mark E. Rupp is a scholar working on Applied Microbiology and Biotechnology, Clinical Biochemistry and Emergency Medical Services, having authored 186 papers that have together received 12.3k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (55 papers), Bacterial Identification and Susceptibility Testing (35 papers), Central Venous Catheters and Hemodialysis (32 papers), Infection Control in Healthcare (23 papers), Infective Endocarditis Diagnosis and Management (21 papers), Bacterial biofilms and quorum sensing (20 papers), Streptococcal Infections and Treatments (19 papers) and Antibiotic Use and Resistance (16 papers). The work is most often cited by research in Emergency Medical Services (4.0k citations), Applied Microbiology and Biotechnology (716 citations) and Infectious Diseases (4.6k citations). Mark E. Rupp has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Paul D. Fey, Leonard A. Mermel, Naomi P. O’Grady, Peter C. Iwen, Lillian A. Burns, E. Patchen Dellinger, Pamela A. Lipsett, Jeffrey Garland, Issam Raad and Michele L. Pearson. Their work appears in journals such as Infection Control and Hospital Epidemiology, Open Forum Infectious Diseases, Clinical Infectious Diseases, American Journal of Infection Control and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact